These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1848974)

  • 21. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N; Giantin M; Crivellente F; Ferraresso S; Faustinelli I; Dacasto M; Cristofori P
    J Appl Toxicol; 2015 Jan; 35(1):90-103. PubMed ID: 25580480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
    Bandyopadhyay S; Klaunig JE; Somani P
    Hepatology; 1990 Jul; 12(1):48-58. PubMed ID: 2373484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone-induced lymphocyte toxicity and mitochondrial function.
    Yasuda SU; Sausville EA; Hutchins JB; Kennedy T; Woosley RL
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):94-100. PubMed ID: 8797142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone-induced hepatic phospholipidosis: correlation of morphological and biochemical findings in an animal model.
    Pirovino M; Müller O; Zysset T; Honegger U
    Hepatology; 1988; 8(3):591-8. PubMed ID: 3371876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone.
    Hostetler KY; Giordano JR; Jellison EJ
    Biochim Biophys Acta; 1988 Apr; 959(3):316-21. PubMed ID: 3355852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.
    Liu FL; Cohen RD; Downar E; Butany JW; Edelson JD; Rebuck AS
    Thorax; 1986 Feb; 41(2):100-5. PubMed ID: 3010484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies.
    Somani P
    J Clin Pharmacol; 1989 May; 29(5):405-12. PubMed ID: 2544634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between amiodarone dosage, drug concentrations, and adverse side effects.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):931-5. PubMed ID: 6613839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin E reduces accumulation of amiodarone and desethylamiodarone and inhibits phospholipidosis in cultured human cells.
    Honegger UE; Scuntaro I; Wiesmann UN
    Biochem Pharmacol; 1995 Jun; 49(12):1741-5. PubMed ID: 7598736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipid composition of rat lung after amiodarone treatment.
    Chatelain P; Brotelle R
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):407-18. PubMed ID: 4081325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in saccharide and phospholipid content associated with drug storage in cultured rabbit aorta muscle cells.
    Ruben Z; Anderson SN; Kacew S
    Lab Invest; 1991 Apr; 64(4):574-84. PubMed ID: 2016860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite.
    Talajic M; DeRoode MR; Nattel S
    Circulation; 1987 Jan; 75(1):265-71. PubMed ID: 3791608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipid.
    Wilson BD; Clarkson CE; Lippmann ML
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1110-4. PubMed ID: 2024822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone-associated changes in human neutrophils.
    Somani P; Simon VA; Temesy-Armos PN; Gross SA; Didio LJ
    Am J Cardiol; 1986 Mar; 57(8):666-72. PubMed ID: 3953455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.
    Martin WJ; Howard DM
    Am J Pathol; 1985 Sep; 120(3):344-50. PubMed ID: 2994482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis.
    Joshi UM; Rao P; Kodavanti S; Lockard VG; Mehendale HM
    Biochim Biophys Acta; 1989 Aug; 1004(3):309-20. PubMed ID: 2758025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometry, with double staining with Nile red and anti-CD3 antibody, to detect phospholipidosis in peripheral blood lymphocytes of rats treated with amiodarone.
    Perico ME; Crivellente F; Faustinelli I; Suozzi A; Cristofori P
    Cell Biol Toxicol; 2009 Dec; 25(6):587-98. PubMed ID: 19105033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
    Martin WJ; Standing JE
    J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
    Adams PC; Holt DW; Storey GC; Morley AR; Callaghan J; Campbell RW
    Circulation; 1985 Nov; 72(5):1064-75. PubMed ID: 3930086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in hepatic drug accumulation and enzyme induction after chronic amiodarone feeding of two rat strains: role of the hydroxylator phenotype?
    Pirovino M; Honegger U; Müller O; Zysset T; Küpfer A; Tinel M; Pessayre D
    Br J Pharmacol; 1990 Jan; 99(1):35-40. PubMed ID: 2331573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.